• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Treatment of primary tuberculosis in children].

作者信息

Bourrillon A

机构信息

Hôpital Robert-Debré, Paris, France.

出版信息

Pediatrie. 1993;48(12):888-93.

PMID:8047400
Abstract

The increased prevalence of tuberculosis during the past years incites to a rigorous attitude in screening and treatment of primary tuberculosis. The authors underlines the importance of the prevention by BCG vaccination and of careful screening using correctly performed Mantoux test. The treatment of primary tuberculosis is different whether it is latent (tuberculin positive children without evidence of disease) or patent (with clinical or radiological signs, mycobacterium tuberculosis identification). For latent tuberculosis a two drugs therapy with isoniazid an rifampicine during 6 months is recommended. For patent tuberculosis the author recommands a four drugs therapy (isoniazide, rifampicine, ethambutol, pyrazinamide) for 2 months (3 months in case of hematogenous dissemination with acute miliary or meningitis) followed by a two drugs regimen (isoniazide, rifampicine) for 4 to 9 months. Corticosteroids are indicated when atelectasis resulting from bronchial obstruction is present.

摘要

相似文献

1
[Treatment of primary tuberculosis in children].
Pediatrie. 1993;48(12):888-93.
2
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.采用异烟肼、利福平、乙胺丁醇和吡嗪酰胺治疗耐异烟肼结核病6个月。
Int J Tuberc Lung Dis. 2002 Nov;6(11):952-8.
3
Current concept in the diagnosis and treatment of childhood pulmonary tuberculosis.儿童肺结核诊断与治疗的当前概念
J Indian Med Assoc. 1996 Oct;94(10):381-4.
4
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].[耐异烟肼或耐利福平结核病的特征及治疗结果]
Kekkaku. 2003 Oct;78(10):611-7.
5
[Tuberculosis].[结核病]
Rev Prat. 2002 Oct 15;52(16):1809-20.
6
A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.口服短程疗法治疗痰菌阳性肺结核的对照临床试验。结核病研究中心。
Int J Tuberc Lung Dis. 1997 Dec;1(6):509-17.
7
Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus?吡嗪酰胺加rifampicin联合用药治疗未感染人类免疫缺陷病毒的潜伏性结核感染患者是否安全?
Int J Tuberc Lung Dis. 2005 Mar;9(3):276-81.
8
Pharmacokinetics of isoniazid in pulmonary tuberculosis--a comparative study at two dose levels.异烟肼在肺结核中的药代动力学——两种剂量水平的比较研究
Indian Pediatr. 1996 Apr;33(4):287-91.
9
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.耐多药肺结核12个月治疗方案的结果
Int J Tuberc Lung Dis. 2002 Dec;6(12):1102-9.
10
[Pulmonary tuberculosis in children: its age-dependent aspects].
An Esp Pediatr. 1998 Mar;48(3):251-5.